Interferon-Gamma Release Assay (IGRA)
Showing 1 - 25 of 9,315
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
Assess the IGRA Positivity in Populations With a High TB Burden
Recruiting
- Tuberculosis, Pulmonary
-
Bloemfontein, South Africa
- +8 more
Apr 6, 2022
Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)
Enrolling by invitation
- Tuberculous Uveitis
- Anti Tuberculosis Drug
- Prednisone tablet
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo National Central General Hospital
Sep 12, 2021
Interferon-Gamma Release Assays in Tuberculosis - HIV
Completed
- Tuberculosis
- HIV
- Interferon-Gamma Release Assay
- RT-23
-
Cape Town, Western Cape, South AfricaUniversity of Stellenbosch
Jan 3, 2022
Methods in People Living With Retroviral Infection in Liberia
Active, not recruiting
- Tuberculosis
- HIV
-
Bethesda, Maryland
- +4 more
Jan 14, 2023
Tuberculosis; Uveitis (Manifestation), Anti-Tuberculous Drug Reaction, Tuberculous Uveitis Trial in Jakarta Pusat (Fixed drug
Unknown status
- Tuberculosis; Uveitis (Manifestation)
- +2 more
- Fixed drug combination (FDC) of ATT and Oral steroid
-
Jakarta Pusat, Jakarta, IndonesiaRSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
Oct 1, 2019
Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,
Recruiting
- Sarcoidosis
- +2 more
- Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
-
Chicago, IllinoisNorthwestern Medicine
Dec 6, 2021
Performance Evaluation of the VIDAS TB-IGRA Assay.
Completed
- Active Tuberculosis
- +2 more
- Blood draw and IGRA test
-
Palo Alto, California
- +23 more
Jul 14, 2021
Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)
Not yet recruiting
- Tuberculosis
- BNT164a1
- +2 more
- (no location specified)
Jan 18, 2023
Bullous Dermatoses, Psoriasis, COVID-19 Vaccines Trial in Ratchathewi (tozinameran)
Recruiting
- Bullous Dermatoses
- +2 more
- tozinameran
-
Ratchathewi, Bangkok, ThailandDermatology outpatient clinic, Somdech Phra Debaratana Medical C
Aug 22, 2022
Latent Tuberculosis Trial in Ramat Gan, Ramat-Gan (Answering the study Questionnaire and blood sampling for Interferon gamma
Completed
- Latent Tuberculosis
- Answering the study Questionnaire and blood sampling for Interferon gamma release assay (IGRA)
-
Ramat Gan, Israel
- +1 more
Jan 24, 2019
Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)
Not yet recruiting
- Tuberculosis
- M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
- Placebo
-
Bandung, Indonesia
- +59 more
Sep 25, 2023
Interferon Gamma Release Assays in Predicting Active
Completed
- Tuberculosis
- Latent Tuberculosis
-
Southall, London, United Kingdom
- +2 more
Sep 29, 2020
Rheumatoid Arthritis Trial in Dhaka (Baricitinib 4 MG, Baricitinib 2 MG)
Recruiting
- Rheumatoid Arthritis
- Baricitinib 4 MG
- Baricitinib 2 MG
-
Dhaka, [Other], BangladeshDr. Md. Sadikul islam
Dec 13, 2022
Performance of IGRAs for TB Infection Diagnosis in Elderly
Terminated
- Ageing
- Tuberculosis
- Blood samples
-
Bondy, France
- +2 more
May 27, 2021
HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)
Not yet recruiting
- HIV I Infection
- Tuberculosis
- MTBVAC
- BCG
-
Westdene, Gauteng,, South Africa
- +15 more
Jul 21, 2023
Assessing the Ability of the T-SPOT®.TB Test (IQ)
Completed
- Tuberculosis
-
Brownsville, TexasUniversity of Texas Health
Feb 22, 2021
IGRA in Screening and Monitoring for TB During Anti TNF Therapy
Completed
- Inflammatory Bowel Disease
- +4 more
-
Hong Kong, Hong KongPrince of Wales Hospital
Apr 27, 2020
Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö
Recruiting
- Latent Tuberculosis
- +2 more
-
Malmö, Skåne, SwedenSkåne University Hospital
Nov 10, 2022
Tuberculin Skin Test and Interferon-Gamma Release Assays in
Completed
- Latent Tuberculosis Infection
- Tuberculosis
-
Phoenix, Arizona
- +9 more
Jan 27, 2021
HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)
Recruiting
- HIV Seropositivity
- +3 more
- Blood draw
-
Ghent, East Flanders, BelgiumUH Ghent
Jan 4, 2023
Tuberculosis Infection Trial in United States (BCG (Tokyo 172) vaccine, Placebo)
Recruiting
- Tuberculosis Infection
- BCG (Tokyo 172) vaccine
- Placebo
-
Birmingham, Alabama
- +5 more
Dec 16, 2021
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Latent Tuberculosis Trial in London (IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection)
Active, not recruiting
- Latent Tuberculosis
- IGRA blood test used as a tool for opt-out screening for latent Tuberculsis infection
-
London, Essex, United Kingdom
- +2 more
Sep 21, 2021
Chronic Kidney Disease 5D, Chronic Kidney Disease 5T Trial in Istanbul (SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®))
Completed
- Chronic Kidney Disease 5D
- Chronic Kidney Disease 5T
- SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®)
-
Istanbul, Turkey
- +5 more
Jul 19, 2022